# Jasper Therapeutics, Inc.: filings

JSPR · Nasdaq · CIK 1788028 · [Healthcare](/sectors/healthcare.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/jspr.md) · [Financials](/companies/jspr/financials.md) · [Filings](/companies/jspr/filings.md) · [Insiders](/companies/jspr/insiders.md)

## Reports and events: 142 filings

Newest first, by EDGAR acceptance time (Eastern). Filter with ?form= one of: `periodic`, `8-K`, `10-K`, `10-Q`, `4`, `proxy`, `13dg`, `all`, or any form this company filed (4 121, 8-K 88, 3 33, SC 13G/A 22, 10-Q 20, SC 13G 15, CORRESP 14, 425 12, UPLOAD 12, 144 10, DEF 14A 9, 424B3 8, 424B5 8, EFFECT 8, 10-K 7, DEFA14A 6, S-8 6, SCHEDULE 13G/A 6, SCHEDULE 13G 5, ARS 4, PRE 14A 4, S-3 4, S-4/A 4, 10-K/A 3, 8-K/A 3, S-1/A 3, S-8 POS 3, 10-Q/A 2, 25-NSE 2, POS AM 2, S-1 2, SC 13D 2, SCHEDULE 13D/A 2, SEC STAFF LETTER 2, 3/A 1, 424B4 1, 8-A12B 1, CERT 1, D 1, DRS 1, NT 10-Q 1, S-4 1, SC 13D/A 1, SC TO-I 1, SC TO-I/A 1).

| Filed | Accepted | Form | What it is | Accession |
| --- | --- | --- | --- | --- |
| 2026-10-19 | 13:33 ET | [DEF 14A](/filings/0001213900-26-110751.md) | Proxy statement, period 2026-11-13 | 0001213900-26-110751 |
| 2026-10-15 | 12:00 ET | [8-K](/filings/0001213900-26-109587.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001213900-26-109587 |
| 2026-10-07 | 12:05 ET | [8-K](/filings/0001213900-26-107402.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001213900-26-107402 |
| 2026-10-05 | 12:00 ET | [8-K](/filings/0001213900-26-106651.md) | 5.07 Shareholder vote results | 0001213900-26-106651 |
| 2026-10-05 | 22:54 ET | [8-K/A](/filings/0001213900-26-106574.md) | 9.01 Financial statements and exhibits | 0001213900-26-106574 |
| 2026-10-01 | 21:29 ET | [8-K/A](/filings/0001213900-26-105924.md) | 9.01 Financial statements and exhibits | 0001213900-26-105924 |
| 2026-09-28 | 20:44 ET | [8-K](/filings/0001213900-26-104101.md) | 5.02 Departure or appointment of officers or directors | 0001213900-26-104101 |
| 2026-09-04 | 19:08 ET | [DEF 14A](/filings/0001213900-26-097572.md) | Proxy statement, period 2026-09-30 | 0001213900-26-097572 |
| 2026-08-26 | 20:15 ET | [8-K](/filings/0001213900-26-093979.md) | 1.01 Entry into a material agreement | 0001213900-26-093979 |
| 2026-08-14 | 20:07 ET | [8-K](/filings/0001213900-26-090055.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001213900-26-090055 |
| 2026-08-14 | 15:00 ET | [10-Q](/filings/0001213900-26-089592.md) | Quarterly report, period 2026-06-30 | 0001213900-26-089592 |
| 2026-08-03 | 20:47 ET | [8-K](/filings/0001213900-26-084687.md) | 5.07 Shareholder vote results | 0001213900-26-084687 |
| 2026-07-31 | 10:06 ET | [8-K](/filings/0001213900-26-083563.md) | 8.01 Other events | 0001213900-26-083563 |
| 2026-07-20 | 21:01 ET | [SCHEDULE 13D/A](/filings/0000921895-26-001834.md) | Ownership report, active investor, amended | 0000921895-26-001834 |
| 2026-07-17 | 01:50 ET | [8-K](/filings/0001213900-26-078887.md) | 1.01 Entry into a material agreement; 2.01 Completion of an acquisition or disposition; 3.02 Unregistered sale of equity; 5.02 Departure or appointment of officers or directors; 5.03 Amendment to articles or bylaws; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001213900-26-078887 |
| 2026-07-16 | 21:15 ET | [8-K](/filings/0001213900-26-078781.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001213900-26-078781 |
| 2026-06-15 | 20:03 ET | [DEF 14A](/filings/0001213900-26-068765.md) | Proxy statement, period 2026-07-31 | 0001213900-26-068765 |
| 2026-06-09 | 20:05 ET | [8-K](/filings/0001213900-26-066782.md) | 3.01 Delisting notice | 0001213900-26-066782 |
| 2026-06-01 | 12:01 ET | [8-K](/filings/0001213900-26-063157.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001213900-26-063157 |
| 2026-05-21 | 20:01 ET | [8-K](/filings/0001213900-26-060029.md) | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001213900-26-060029 |
| 2026-05-14 | 20:05 ET | [10-Q](/filings/0001213900-26-056595.md) | Quarterly report, period 2026-03-31 | 0001213900-26-056595 |
| 2026-05-14 | 20:05 ET | [8-K](/filings/0001213900-26-056596.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001213900-26-056596 |
| 2026-04-30 | 20:01 ET | [10-K/A](/filings/0001213900-26-050178.md) | Annual report, amended, period 2025-12-31 | 0001213900-26-050178 |
| 2026-03-30 | 21:33 ET | [8-K](/filings/0001213900-26-036448.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001213900-26-036448 |
| 2026-03-30 | 21:32 ET | [10-K](/filings/0001213900-26-036426.md) | Annual report, period 2025-12-31 | 0001213900-26-036426 |
| 2026-01-08 | 12:06 ET | [8-K](/filings/0001213900-26-002329.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001213900-26-002329 |
| 2026-01-07 | 21:35 ET | [8-K](/filings/0001213900-26-002185.md) | 5.02 Departure or appointment of officers or directors; 8.01 Other events; 9.01 Financial statements and exhibits | 0001213900-26-002185 |
| 2025-12-02 | 12:06 ET | [8-K](/filings/0001213900-25-116943.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001213900-25-116943 |
| 2025-11-10 | 13:17 ET | [10-Q](/filings/0001213900-25-107884.md) | Quarterly report, period 2025-09-30 | 0001213900-25-107884 |
| 2025-11-10 | 13:05 ET | [8-K](/filings/0001213900-25-107874.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001213900-25-107874 |
| 2025-09-23 | 21:07 ET | [SCHEDULE 13D/A](/filings/0000921895-25-002600.md) | Ownership report, active investor, amended | 0000921895-25-002600 |
| 2025-09-19 | 20:38 ET | [8-K](/filings/0001213900-25-089584.md) | 1.01 Entry into a material agreement; 8.01 Other events; 9.01 Financial statements and exhibits | 0001213900-25-089584 |
| 2025-08-13 | 20:10 ET | [8-K](/filings/0001213900-25-075678.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001213900-25-075678 |
| 2025-08-13 | 20:00 ET | [10-Q](/filings/0001213900-25-075635.md) | Quarterly report, period 2025-06-30 | 0001213900-25-075635 |
| 2025-07-09 | 12:05 ET | [8-K](/filings/0001213900-25-062194.md) | 2.05 Exit or disposal costs; 5.02 Departure or appointment of officers or directors; 8.01 Other events; 9.01 Financial statements and exhibits | 0001213900-25-062194 |
| 2025-07-07 | 11:35 ET | [8-K](/filings/0001213900-25-061632.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001213900-25-061632 |
| 2025-07-03 | 20:01 ET | [8-K](/filings/0001213900-25-061471.md) | 5.07 Shareholder vote results | 0001213900-25-061471 |
| 2025-06-16 | 10:19 ET | [8-K](/filings/0001213900-25-054465.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001213900-25-054465 |
| 2025-05-19 | 12:00 ET | [DEF 14A](/filings/0001213900-25-045086.md) | Proxy statement, period 2025-07-03 | 0001213900-25-045086 |
| 2025-05-12 | 20:05 ET | [8-K](/filings/0001213900-25-042017.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001213900-25-042017 |
| 2025-05-12 | 20:01 ET | [10-Q](/filings/0001213900-25-042011.md) | Quarterly report, period 2025-03-31 | 0001213900-25-042011 |
| 2025-03-19 | 20:42 ET | [8-K](/filings/0001213900-25-025123.md) | 1.01 Entry into a material agreement; 1.02 Termination of a material agreement; 9.01 Financial statements and exhibits | 0001213900-25-025123 |
| 2025-02-28 | 14:20 ET | [10-K](/filings/0001213900-25-018384.md) | Annual report, period 2024-12-31 | 0001213900-25-018384 |
| 2025-02-27 | 13:05 ET | [8-K](/filings/0001213900-25-017656.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001213900-25-017656 |
| 2025-01-08 | 12:05 ET | [8-K](/filings/0001213900-25-001810.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001213900-25-001810 |
| 2024-11-07 | 12:42 ET | [8-K](/filings/0001213900-24-095175.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001213900-24-095175 |
| 2024-11-07 | 12:30 ET | [10-Q](/filings/0001213900-24-095173.md) | Quarterly report, period 2024-09-30 | 0001213900-24-095173 |
| 2024-10-15 | 10:03 ET | [8-K](/filings/0001213900-24-087394.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001213900-24-087394 |
| 2024-08-13 | 11:00 ET | [10-Q](/filings/0001213900-24-067897.md) | Quarterly report, period 2024-06-30 | 0001213900-24-067897 |
| 2024-06-20 | 10:02 ET | [8-K](/filings/0001213900-24-053982.md) | 5.02 Departure or appointment of officers or directors; 8.01 Other events; 9.01 Financial statements and exhibits | 0001213900-24-053982 |

Page 1 of 3. [Older](/companies/jspr/filings.md?page=2)
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 24, 2026, 15:15 ET. No prices; not investment advice.